Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cypress Minerals is a biotechnology and nutraceutical company that specializes in the production of high-quality, bioavailable mineral ingredients. Formerly known as Cypress Systems, Inc., the company rebranded in 2024 to focus on its Resilient Minerals platform, which provides organically bound minerals designed for optimal absorption and physiological performance. Their flagship product, SelenoExcell, is a high-selenium yeast that has been extensively researched in collaboration with the National Cancer Institute for its potential in cancer prevention. The company serves as a B2B supplier to the dietary supplement and functional food industries, offering a range of mineralized yeasts and fully-reacted chelated minerals. Cypress Minerals is also recognized for its commitment to social impact, donating a portion of its sales to global humanitarian causes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cypress Minerals.